Funded Grants

PI Namesort descending Organization Title Project Number Major Program / Research Group Funding Opportunity Announcement
Bender, Catherine M. University Of Pittsburgh At Pittsburgh Influence of Exercise on Neurocognitive Function in Breast Cancer 5R01CA196762-05 Community Oncology and Prevention Trials, Supportive Care and Symptom Management, Cognitive Dysfunction PA-13-302
Berenberg, Jeffrey Lee University Of Hawaii At Manoa The Hawaii Minority/Underserved NCORP 5UG1CA189804-07 Community Oncology and Prevention Trials, NCI Community Oncology Research Program, NCORP Minority Underserved RFA-CA-18-017
Beretta, Laura UNIVERSITY OF TX MD ANDERSON CAN CTR Prevention of Hepatocellular Carcinoma (HCC) Associated with Non Alcoholic Steatohepatitis (NASH) 261201500018I-0-26100007-1 PREVENT Cancer Preclinical Drug Development Program
Beretta, Laura University Of Tx Md Anderson Can Ctr Early Detection of Hepatocellular Carcinoma 5R01CA195524-05 Cancer Biomarkers PAR-13-189
Bergsagel, Peter Leif Mayo Clinic Arizona Mutations that Distinguish Benign from Malignant Plasma Cell Neoplasams 5R01CA195688-05 Cancer Biomarkers PA-13-302
Bertagnolli, Monica M. Alliance Nctn Foundation Alliance NCORP Research Base 7UG1CA189823-07 Community Oncology and Prevention Trials, NCI Community Oncology Research Program, NCORP Research Bases PA-18-590
Bertozzi, Carolyn Stanford University Chemical Glycoproteomics 5R01CA200423-17 Cancer Biomarkers PA-13-302
Bettegowda, Chetan Johns Hopkins University Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluid 1R01CA230400-01 Cancer Biomarkers PA16-160
Bettegowda, Chetan Johns Hopkins University Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluid 5R37CA230400-03 Cancer Biomarkers PA-16-160
Bhatia, Smita University Of Alabama At Birmingham Comprehensive Approach to Improve Medicine Adherence in Pediatric Leukmia 5R01CA174683-05 Community Oncology and Prevention Trials, Supportive Care and Symptom Management, Medication Adherence PA-12-022
Bissonnette, Bruce Marc University Of Chicago CXCR4 as a target for colon cancer chemoprevention 5R01CA240710-02 Chemopreventive Agent Development PA-18-484
Bissonnette, Bruce Marc University Of Chicago Development of 5hmC and 5mC biomarkers in cell-free circulating DNA for sensitive colon cancer detection and prognosis 5U01CA217078-04 Early Detection, Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial PAR-15-297
Blanke, Charles D. Oregon Health & Science University SWOG NCORP Research Base 5UG1CA189974-07 Community Oncology and Prevention Trials, NCI Community Oncology Research Program, NCORP Research Bases RFA-CA-18-015
Borges, Chad R Arizona State University-Tempe Campus Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity 5R33CA217702-03 Cancer Biomarkers RFA-CA-17-013
Brand, Randall University Of Pittsburgh At Pittsburgh Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms 5U01CA200466-05 Cancer Biomarkers, Early Detection Research Network, EDRN Clinical Validation Center RFA-CA-14-015

Pages